Comparison of Retatrutide's GLP-1/GIP/glucagon triple receptor agonism against Semaglutide's selective GLP-1 mechanism, with research dose ranges and trial data.
View the full PeptX research peptide catalogue, or browse Retatrutide, Tirzepatide, Semaglutide, BPC-157, TB-500 and GHK-Cu.